Protection of human immunodeficiency virus encephalitis by a switch from zidovudine to didanosine.

類似資料

• Population Pharmacokinetics of Nevirapine, Zidovudine, and Didanosine in Human Immunodeficiency Virus-Infected Patients
  著者:: Zhou, Xiao-Jian, 等
  出版事項: (1999)
• Ganciclovir antagonizes the anti-human immunodeficiency virus type 1 activity of zidovudine and didanosine in vitro.
  著者:: Medina, D J, 等
  出版事項: (1992)
• Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine.
  著者:: Frenkel, L M, 等
  出版事項: (1995)
• Determination of human immunodeficiency virus RNA in plasma and cellular viral DNA genotypic zidovudine resistance and viral load during zidovudine-didanosine combination therapy.
  著者:: Holodniy, M, 等
  出版事項: (1995)
• Human Immunodeficiency Virus Polymorphisms and Zidovudine Resistance
  著者:: Nicastri, Emanuele, 等
  出版事項: (2003)